• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成像区域性肺功能:开发吸入性抗菌疗法的关键工具。

Imaging regional lung function: a critical tool for developing inhaled antimicrobial therapies.

机构信息

Department of Mechanical & Aerospace Engineering, Monash University, Victoria 3800, Australia.

出版信息

Adv Drug Deliv Rev. 2015 May;85:100-9. doi: 10.1016/j.addr.2015.03.010. Epub 2015 Mar 27.

DOI:10.1016/j.addr.2015.03.010
PMID:25819486
Abstract

Alterations in regional lung function due to respiratory infection have a significant effect on the deposition of inhaled treatments. This has consequences for treatment effectiveness and hence recovery of lung function. In order to advance our understanding of respiratory infection and inhaled treatment delivery, we must develop imaging techniques that can provide regional functional measurements of the lung. In this review, we explore the role of functional imaging for the assessment of respiratory infection and development of inhaled treatments. We describe established and emerging functional lung imaging methods. The effect of infection on lung function is described, and the link between regional disease, function, and inhaled treatments is discussed. The potential for lung function imaging to provide unique insights into the functional consequences of infection, and its treatment, is also discussed.

摘要

由于呼吸道感染导致的区域性肺功能改变对吸入治疗的沉积有重大影响。这对治疗效果和肺功能的恢复有影响。为了提高我们对呼吸道感染和吸入治疗的认识,我们必须开发能够提供肺部区域性功能测量的成像技术。在这篇综述中,我们探讨了功能成像在评估呼吸道感染和开发吸入治疗中的作用。我们描述了已建立和新兴的功能性肺部成像方法。描述了感染对肺功能的影响,并讨论了区域性疾病、功能和吸入治疗之间的联系。还讨论了肺功能成像提供对感染及其治疗的功能后果的独特见解的潜力。

相似文献

1
Imaging regional lung function: a critical tool for developing inhaled antimicrobial therapies.成像区域性肺功能:开发吸入性抗菌疗法的关键工具。
Adv Drug Deliv Rev. 2015 May;85:100-9. doi: 10.1016/j.addr.2015.03.010. Epub 2015 Mar 27.
2
Inhaled antibiotics for gram-negative respiratory infections.吸入用抗生素治疗革兰氏阴性呼吸道感染。
Future Med Chem. 2011 Oct;3(13):1663-77. doi: 10.4155/fmc.11.114.
3
MP-376 (Aeroquin) for chronic Pseudomonas aeruginosa infections.MP-376(Aeroquin)治疗慢性铜绿假单胞菌感染。
Expert Opin Investig Drugs. 2013 Feb;22(2):267-76. doi: 10.1517/13543784.2013.748034. Epub 2012 Nov 24.
4
Delivery of antibiotics to the respiratory tract: an update.抗生素在呼吸道的递送:最新进展
Expert Opin Drug Deliv. 2009 Sep;6(9):897-905. doi: 10.1517/17425240903110710.
5
Inhaled antimicrobial therapy - barriers to effective treatment.吸入性抗菌治疗 - 有效治疗的障碍。
Adv Drug Deliv Rev. 2015 May;85:24-43. doi: 10.1016/j.addr.2014.08.013. Epub 2014 Sep 1.
6
Inhaled ciprofloxacin for chronic airways infections caused by Pseudomonas aeruginosa.吸入环丙沙星治疗铜绿假单胞菌引起的慢性气道感染。
Expert Rev Anti Infect Ther. 2012 Dec;10(12):1439-46. doi: 10.1586/eri.12.136.
7
Eradication of Pseudomonas aeruginosa in cystic fibrosis.根除囊性纤维化患者体内的铜绿假单胞菌。
Eur Respir J. 2006 Feb;27(2):438-9. doi: 10.1183/09031936.06.00118805.
8
Inhaled liposomal amikacin.吸入用脂质体硫酸阿米卡星。
Expert Rev Respir Med. 2014 Aug;8(4):401-9. doi: 10.1586/17476348.2014.918507. Epub 2014 May 31.
9
Inhaled antibiotics in Cystic Fibrosis (CF) and non-CF bronchiectasis.囊性纤维化(CF)和非CF支气管扩张症中的吸入性抗生素
Semin Respir Crit Care Med. 2015 Apr;36(2):267-86. doi: 10.1055/s-0035-1547346. Epub 2015 Mar 31.
10
Patient-specific modeling of regional antibiotic concentration levels in airways of patients with cystic fibrosis: are we dosing high enough?囊性纤维化患者气道中区域抗生素浓度水平的个体化建模:我们的给药剂量足够高吗?
PLoS One. 2015 Mar 3;10(3):e0118454. doi: 10.1371/journal.pone.0118454. eCollection 2015.

引用本文的文献

1
Ultrasound-Based Local Lung Motion Assessment Using Synthetic Lateral Phase.基于合成横向相位的超声局部肺运动评估
J Clin Ultrasound. 2025 May;53(4):639-646. doi: 10.1002/jcu.23908. Epub 2025 Jan 25.
2
Acoustic Lung Imaging Utilized in Continual Assessment of Patients with Obstructed Airway: A Systematic Review.声学分段成像在气道阻塞患者连续评估中的应用:系统评价。
Sensors (Basel). 2023 Jul 7;23(13):6222. doi: 10.3390/s23136222.
3
Lung function measurements in preclinical research: What has been done and where is it headed?
临床前研究中的肺功能测量:已取得的成果及未来发展方向?
Front Physiol. 2023 Mar 22;14:1130096. doi: 10.3389/fphys.2023.1130096. eCollection 2023.
4
Affordable, portable and self-administrable electrical impedance tomography enables global and regional lung function assessment.经济实惠、便于携带且可自主操作的电阻抗断层成像技术可实现全球和区域性肺功能评估。
Sci Rep. 2022 Nov 30;12(1):20613. doi: 10.1038/s41598-022-24330-2.
5
The physics of respiratory particle generation, fate in the air, and inhalation.呼吸性颗粒的产生、在空气中的归宿及吸入的物理学原理。
Nat Rev Phys. 2022;4(11):723-734. doi: 10.1038/s42254-022-00506-7. Epub 2022 Aug 31.
6
Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era.基于膜破坏肽/肽模拟物的疗法:在耐药时代对抗细菌和癌症的有前景的系统。
Acta Pharm Sin B. 2021 Sep;11(9):2609-2644. doi: 10.1016/j.apsb.2021.07.014. Epub 2021 Jul 21.
7
Defect distribution index: A novel metric for functional lung MRI in cystic fibrosis.缺陷分布指数:囊性纤维化功能肺部 MRI 的新指标。
Magn Reson Med. 2021 Dec;86(6):3224-3235. doi: 10.1002/mrm.28947. Epub 2021 Aug 2.
8
An Inhalable Theranostic System for Local Tuberculosis Treatment Containing an Isoniazid Loaded Metal Organic Framework Fe-MIL-101-NH2-From Raw MOF to Drug Delivery System.一种用于局部结核病治疗的可吸入治疗诊断系统,包含负载异烟肼的金属有机框架Fe-MIL-101-NH2——从原始金属有机框架到药物递送系统
Pharmaceutics. 2019 Dec 17;11(12):687. doi: 10.3390/pharmaceutics11120687.
9
Quantification of image texture in X-ray phase-contrast-enhanced projection images of in vivo mouse lungs observed at varied inflation pressures.在不同充气压力下观察到的活体小鼠肺部X射线相衬增强投影图像中图像纹理的量化。
Physiol Rep. 2019 Aug;7(16):e14208. doi: 10.14814/phy2.14208.
10
Imaging of pulmonary perfusion using subtraction CT angiography is feasible in clinical practice.采用减影 CT 血管造影术进行肺灌注成像在临床实践中是可行的。
Eur Radiol. 2019 Mar;29(3):1408-1414. doi: 10.1007/s00330-018-5740-4. Epub 2018 Sep 25.